NCT00038792View on ClinicalTrials.gov

Phase I/II Trial rHuKFG for the Treatment of Steroid Refractory Gastrointestinal Acute GVHD

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

October 31, 2000

Primary Completion Date

January 31, 2003

Study Completion Date

January 31, 2003

Conditions
Acute Graft Versus Host Disease
Interventions
DRUG

Recombinant Human Keratinocyte Growth Factor

Trial Locations (1)

77030

MD Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

Amgen
All Listed Sponsors
collaborator

Amgen

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER

NCT00038792 - Phase I/II Trial rHuKFG for the Treatment of Steroid Refractory Gastrointestinal Acute GVHD | Biotech Hunter | Biotech Hunter